Please use this identifier to cite or link to this item: http://dspace.mediu.edu.my:8181/xmlui/handle/1721.1/3954
Full metadata record
DC FieldValueLanguage
dc.creatorTan, Wilson Hor Keong-
dc.creatorLee, Timothy-
dc.creatorWang, Chi-Hwa-
dc.date2003-12-16T14:47:43Z-
dc.date2003-12-16T14:47:43Z-
dc.date2004-01-
dc.date.accessioned2013-10-09T02:33:18Z-
dc.date.available2013-10-09T02:33:18Z-
dc.date.issued2013-10-09-
dc.identifierhttp://hdl.handle.net/1721.1/3954-
dc.identifier.urihttp://koha.mediu.edu.my:8181/xmlui/handle/1721-
dc.descriptionThis paper presents the computer simulation results on the delivery of Etanidazole (radiosensitiser) to the brain tumor and examines several factors affecting the delivery. The simulation consists of a 3D model of tumor with poly (lactide-co-glycolide) (PLGA) wafers of 1% Etanidzole loading implanted in the resected cavity. A zero-order release device will produce a concentration profile in the tumor which increases with time until the drug in the carrier is depleted. This causes toxicity complications during the later stages of drug treatment. However, for wafers of similar loading, such release results in a higher drug penetration depth and therapeutic index as compared to the double drug burst profile. The numerical accuracy of the model was verified by the similar results obtained in the two-dimensional and three-dimensional models.-
dc.descriptionSingapore-MIT Alliance (SMA)-
dc.format12333 bytes-
dc.formatapplication/pdf-
dc.languageen-
dc.relationMolecular Engineering of Biological and Chemical Systems (MEBCS);-
dc.subjectdrug delivery-
dc.subjectcomputer simulations-
dc.subject3D computer models-
dc.subjectbrain tumor treatment-
dc.subjectzero order release devices-
dc.titleDelivery of Etanidazole to Brain Tumor from PLGA Wafers-
dc.typeArticle-
Appears in Collections:MIT Items

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.